Concepts (100)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammation | 5 | 2026 | 669 | 1.640 |
Why?
|
| Microglia | 3 | 2024 | 69 | 1.580 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2026 | 136 | 1.510 |
Why?
|
| Neurons | 4 | 2024 | 297 | 0.950 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 11 | 0.950 |
Why?
|
| Disease Models, Animal | 4 | 2026 | 1522 | 0.730 |
Why?
|
| Neural Pathways | 1 | 2022 | 122 | 0.730 |
Why?
|
| Hedgehog Proteins | 2 | 2012 | 35 | 0.720 |
Why?
|
| Immunologic Memory | 1 | 2021 | 58 | 0.690 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2012 | 130 | 0.690 |
Why?
|
| Mothers | 1 | 2022 | 126 | 0.690 |
Why?
|
| Schizophrenia | 3 | 2016 | 51 | 0.640 |
Why?
|
| Cytokines | 3 | 2026 | 457 | 0.590 |
Why?
|
| Psychotic Disorders | 2 | 2018 | 23 | 0.550 |
Why?
|
| Dopamine | 2 | 2012 | 24 | 0.450 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 8 | 0.420 |
Why?
|
| Toxoplasmosis | 1 | 2014 | 11 | 0.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 67 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 5 | 2026 | 1672 | 0.400 |
Why?
|
| Poly I-C | 2 | 2026 | 13 | 0.390 |
Why?
|
| Ventral Tegmental Area | 1 | 2012 | 11 | 0.380 |
Why?
|
| Mice | 7 | 2026 | 4848 | 0.380 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 19 | 0.380 |
Why?
|
| Pregnancy | 4 | 2026 | 1261 | 0.370 |
Why?
|
| Animals | 9 | 2026 | 10767 | 0.360 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 14 | 0.350 |
Why?
|
| Mesencephalon | 1 | 2011 | 7 | 0.350 |
Why?
|
| Female | 8 | 2026 | 15748 | 0.230 |
Why?
|
| Fasting | 1 | 2024 | 91 | 0.200 |
Why?
|
| Electroretinography | 1 | 2024 | 180 | 0.200 |
Why?
|
| Receptors, Dopamine | 1 | 2022 | 3 | 0.190 |
Why?
|
| Neostriatum | 1 | 2022 | 7 | 0.190 |
Why?
|
| Cell Lineage | 2 | 2012 | 53 | 0.180 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 58 | 0.180 |
Why?
|
| Chromatin | 1 | 2022 | 76 | 0.180 |
Why?
|
| Ethanol | 1 | 2021 | 126 | 0.160 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 514 | 0.160 |
Why?
|
| Retina | 1 | 2024 | 445 | 0.160 |
Why?
|
| Stress, Psychological | 2 | 2024 | 234 | 0.160 |
Why?
|
| Immunity, Innate | 1 | 2021 | 234 | 0.150 |
Why?
|
| Body Temperature Regulation | 1 | 2019 | 12 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2022 | 524 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 47 | 0.140 |
Why?
|
| Receptors, GABA | 1 | 2018 | 5 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 131 | 0.140 |
Why?
|
| Corticosterone | 1 | 2018 | 35 | 0.140 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 80 | 0.130 |
Why?
|
| Male | 7 | 2024 | 14057 | 0.130 |
Why?
|
| Antibodies, Protozoan | 1 | 2016 | 9 | 0.130 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2016 | 14 | 0.130 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 9 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 42 | 0.120 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2016 | 51 | 0.120 |
Why?
|
| Aging | 1 | 2024 | 1029 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2016 | 94 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 81 | 0.120 |
Why?
|
| Brain | 1 | 2021 | 772 | 0.120 |
Why?
|
| Biomarkers | 2 | 2016 | 787 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 138 | 0.100 |
Why?
|
| Antibodies | 1 | 2014 | 125 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2018 | 684 | 0.100 |
Why?
|
| Bromodeoxyuridine | 1 | 2012 | 10 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2012 | 34 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2012 | 126 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 276 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2024 | 1485 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2012 | 163 | 0.090 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Stem Cells | 1 | 2012 | 123 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 32 | 0.090 |
Why?
|
| Young Adult | 2 | 2016 | 2856 | 0.080 |
Why?
|
| Models, Biological | 1 | 2012 | 471 | 0.080 |
Why?
|
| Humans | 4 | 2021 | 29096 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2012 | 828 | 0.080 |
Why?
|
| Mutation | 1 | 2012 | 873 | 0.070 |
Why?
|
| Time Factors | 1 | 2012 | 1619 | 0.070 |
Why?
|
| Adult | 3 | 2016 | 8081 | 0.070 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2024 | 5 | 0.050 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 5 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2024 | 74 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2024 | 138 | 0.050 |
Why?
|
| Cerebral Cortex | 1 | 2024 | 136 | 0.050 |
Why?
|
| Cognition | 1 | 2024 | 331 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 271 | 0.040 |
Why?
|
| Fetus | 1 | 2019 | 79 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 78 | 0.040 |
Why?
|
| RNA | 1 | 2019 | 111 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 157 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 2016 | 7 | 0.030 |
Why?
|
| Herpesvirus 2, Human | 1 | 2016 | 4 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2016 | 24 | 0.030 |
Why?
|
| Cytomegalovirus | 1 | 2016 | 22 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 80 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 100 | 0.030 |
Why?
|
| Toxoplasma | 1 | 2016 | 33 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 249 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 740 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 902 | 0.030 |
Why?
|
| Adolescent | 1 | 2016 | 3239 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 7458 | 0.010 |
Why?
|